thiodigalactoside has been researched along with Leukemia, T-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bravo-Zehnder, M; Bull, P; Cáceres, M; Cárcamo, C; González, A; Jacobelli, S; Martínez, J; Massardo, L; Oyanadel, C; Pardo, E; Soza, A | 1 |
1 other study(ies) available for thiodigalactoside and Leukemia, T-Cell
| Article | Year |
|---|---|
Galectin-8 binds specific beta1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T cells.
Topics: Androstadienes; Antibodies, Monoclonal; Autoantibodies; Cell Adhesion; Cell Shape; Cell Surface Extensions; Cytochalasin D; Cytoskeleton; Fibronectins; Flavonoids; Galectins; Humans; Integrin beta1; Jurkat Cells; Leukemia, T-Cell; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphoinositide-3 Kinase Inhibitors; Protein Binding; Protein Kinase Inhibitors; rac1 GTP-Binding Protein; Thiogalactosides; Transfection; Wortmannin | 2006 |